Andorra vs Central Europe and the Baltics: Prevalence of current tobacco use, females
Prevalence of current tobacco use, females over time
- Andorra
- Central Europe and the Baltics
How they compare
Andorra currently reports 36.4% against 23.0% in Central Europe and the Baltics, a difference of 13.4%.
That makes Andorra's figure about 1.6 times Central Europe and the Baltics's.
The two have swapped places 1 time across 9 shared years of data; in 2000 it was Central Europe and the Baltics ahead.
Andorra ranks 5th and Central Europe and the Baltics ranks 2nd of 166 countries.
Andorra has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Central Europe and the Baltics | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.8% | 28.0% | 1.8% | Andorra |
| 2010s | 32.4% | 25.6% | 6.8% | Andorra |
| 2020s | 35.8% | 23.3% | 12.4% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, females, Andorra or Central Europe and the Baltics?
- Andorra, at 36.4% against 23.0% in Central Europe and the Baltics as of 2024.
- What is the difference in prevalence of current tobacco use, females between Andorra and Central Europe and the Baltics?
- 13.4%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Central Europe and the Baltics?
- 9 years are reported by both, from 2000 to 2024.
- How do Andorra and Central Europe and the Baltics rank globally for prevalence of current tobacco use, females?
- Andorra ranks 5th and Central Europe and the Baltics ranks 2nd of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use, females (% of female adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the female population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.